PPD adds new lab in Singapore

By Gareth Macdonald

- Last updated on GMT

Related tags: Biotechnology, Pharmaceutical industry

US contract research organisation (CRO) PPD has set its sights on the Asian biopharma sector with new a lab at the heart of Singapore’s rapidly expanding drug development and trial industry.

Steve Lobel, VP of laboratory operations, said the expansion “demonstrates our commitment to deliver high quality specimens and laboratory results for our clients in a growing biopharmaceutical market​.”

According to PPD, the laboratory, which houses identical instrumentation and capacity to its facilities in Belgium, the US and China, will provide analysis services to local biotechs and international players with operations in the country

The firm also stressed that benefits development clients stand to gain from the new lab’s integration into its global network via its Connexion database, which it said would “ensure consistent management and real-time reporting​.”

Booming biotech attracts CROs

Singapore’s status as a global biopharmaceuticals development and manufacturing hub is undeniable, with Lonza’s choice of the country as the location for its new cell therapy plant being only the most recent example.

The primary reason for the current biotech strength is the decade long programme of investment in science education and manufacturing infrastructure that successive governments have undertaken.

As a result a number of international industry players, including Bayer, Schering-Plough and Takeda, have all either set up biopharma manufacturing operations in the country or are developing strong links with academia.

Additionally, Lonza, Baxter, Genentech, GlaxoSmithKline (GSK), Novartis and Millipore are all collaborating to set up a $2m biopharmaceutical manufacturing training facility in the country

The presence of such firms has also attracted contractors of all types. In addition to PPD, which has had an office in the country for than ten years, many other major CROs including Covance, Parexel and MDS Pharma Services, have a presence.

Development group Icon also has a laboratory in Singapore, see today's news in brief​ for more details.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us

Products

View more

Webinars